D-1242-2019 Class III Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1242-2019 was initiated by Zydus Pharmaceuticals USA Inc on Apr 22, 2019 and is designated Class III. Reason for recall: Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of… The recall status is terminated (terminated Jan 14, 2021). Affected quantity: 7668 bottles.

Recall details

Product Type
Drugs
Report Date
May 1, 2019
Initiation Date
Apr 22, 2019
Termination Date
Jan 14, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7668 bottles

Product description

Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05

Reason for recall

Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

Distribution pattern

Nationwide in the USA

Code information

Lot #: Z803518, Exp 08/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1242-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1242-2019. Report a data issue: hello@regdatalab.com.